Back to Clinical Trials
N/ARecruiting

Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)

Sponsored by Bodyport Inc.

About this study

To explore the use of the Bodyport Cardiac Scale in predicting worsening of events due to fluid overload in patients with kidney disease on peritoneal dialysis.

The objective of this study is to explore the utility of hemodynamic biomarkers measured by the Bodyport Cardiac Scale in predicting worsening events attributable to fluid overload among those with kidney disease on peritoneal dialysis. The study will explore individual biomarkers, as well as composite biomarker indices, such as the Congestion Index and a novel PD Index.

Where this study is enrolling (3)

Who can participate

Inclusion criteria

  • ✓1. Age 21 years or older
  • ✓2. Able to speak and read English, or able to speak and read Spanish and has a caregiver or family member who speaks English and can provide assistance
  • ✓3. Able to stand on two bare feet unassisted
  • ✓4. Receiving automated peritoneal dialysis for the treatment of ESKD
  • ✓5. Followed on the Vantive Sharesource Remote Patient Management Platform

Exclusion criteria

  • ✕1. Undergoing or plan to undergo hemodialysis in the next 12 months
  • ✕2. Have a life expectancy of less than 12 months
  • ✕3. Are pregnant or plan to become pregnant during the next 12 months
  • ✕4. Weigh greater than 375 lbs
  • ✕5. Planned kidney transplant within the next 12 months
  • ✕6. Have an implanted neurostimulator system

Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.

Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.

Trial data sourced from ClinicalTrials.gov.